vs

Side-by-side financial comparison of Penumbra Inc (PEN) and Strategic Education, Inc. (STRA). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $305.9M, roughly 1.3× Strategic Education, Inc.). Penumbra Inc runs the higher net margin — 12.3% vs 10.7%, a 1.6% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 0.8%). Strategic Education, Inc. produced more free cash flow last quarter ($77.3M vs $68.0M). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs -1.0%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

Strategic Education, Inc. (SEI) is an education services holding company and is formerly known as Strayer Education, Inc. The company owns for-profit, online Capella University and Strayer University, as well as non-degree programs schools such as DevMountain, Hackbright Academy, and Sophia Learning.

PEN vs STRA — Head-to-Head

Bigger by revenue
PEN
PEN
1.3× larger
PEN
$385.4M
$305.9M
STRA
Growing faster (revenue YoY)
PEN
PEN
+21.4% gap
PEN
22.1%
0.8%
STRA
Higher net margin
PEN
PEN
1.6% more per $
PEN
12.3%
10.7%
STRA
More free cash flow
STRA
STRA
$9.3M more FCF
STRA
$77.3M
$68.0M
PEN
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
-1.0%
STRA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PEN
PEN
STRA
STRA
Revenue
$385.4M
$305.9M
Net Profit
$47.3M
$32.8M
Gross Margin
68.0%
Operating Margin
15.4%
13.4%
Net Margin
12.3%
10.7%
Revenue YoY
22.1%
0.8%
Net Profit YoY
40.6%
10.3%
EPS (diluted)
$1.20
$1.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
STRA
STRA
Q1 26
$305.9M
Q4 25
$385.4M
$323.2M
Q3 25
$354.7M
$319.9M
Q2 25
$339.5M
$321.5M
Q1 25
$324.1M
$303.6M
Q4 24
$315.5M
$311.5M
Q3 24
$301.0M
$306.0M
Q2 24
$299.4M
$312.3M
Net Profit
PEN
PEN
STRA
STRA
Q1 26
$32.8M
Q4 25
$47.3M
$37.9M
Q3 25
$45.9M
$26.6M
Q2 25
$45.3M
$32.3M
Q1 25
$39.2M
$29.7M
Q4 24
$33.7M
$25.3M
Q3 24
$29.5M
$27.7M
Q2 24
$-60.2M
$29.9M
Gross Margin
PEN
PEN
STRA
STRA
Q1 26
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Operating Margin
PEN
PEN
STRA
STRA
Q1 26
13.4%
Q4 25
15.4%
16.0%
Q3 25
13.8%
11.6%
Q2 25
12.0%
14.2%
Q1 25
12.4%
13.1%
Q4 24
13.6%
11.6%
Q3 24
11.7%
11.9%
Q2 24
-27.0%
13.4%
Net Margin
PEN
PEN
STRA
STRA
Q1 26
10.7%
Q4 25
12.3%
11.7%
Q3 25
12.9%
8.3%
Q2 25
13.3%
10.1%
Q1 25
12.1%
9.8%
Q4 24
10.7%
8.1%
Q3 24
9.8%
9.1%
Q2 24
-20.1%
9.6%
EPS (diluted)
PEN
PEN
STRA
STRA
Q1 26
$1.48
Q4 25
$1.20
$1.65
Q3 25
$1.17
$1.15
Q2 25
$1.15
$1.37
Q1 25
$1.00
$1.24
Q4 24
$0.88
$1.05
Q3 24
$0.75
$1.15
Q2 24
$-1.55
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
STRA
STRA
Cash + ST InvestmentsLiquidity on hand
$186.9M
$150.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$1.6B
Total Assets
$1.8B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
STRA
STRA
Q1 26
$150.3M
Q4 25
$186.9M
$148.1M
Q3 25
$321.0M
$172.6M
Q2 25
$421.8M
$164.9M
Q1 25
$376.1M
$182.6M
Q4 24
$324.4M
$184.0M
Q3 24
$280.5M
$222.1M
Q2 24
$288.3M
$256.2M
Stockholders' Equity
PEN
PEN
STRA
STRA
Q1 26
$1.6B
Q4 25
$1.4B
$1.6B
Q3 25
$1.4B
$1.7B
Q2 25
$1.3B
$1.7B
Q1 25
$1.2B
$1.6B
Q4 24
$1.2B
$1.7B
Q3 24
$1.1B
$1.7B
Q2 24
$1.2B
$1.7B
Total Assets
PEN
PEN
STRA
STRA
Q1 26
$2.1B
Q4 25
$1.8B
$2.0B
Q3 25
$1.7B
$2.1B
Q2 25
$1.7B
$2.1B
Q1 25
$1.6B
$2.1B
Q4 24
$1.5B
$2.0B
Q3 24
$1.5B
$2.2B
Q2 24
$1.5B
$2.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
STRA
STRA
Operating Cash FlowLast quarter
$86.5M
$87.4M
Free Cash FlowOCF − Capex
$68.0M
$77.3M
FCF MarginFCF / Revenue
17.7%
25.3%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.83×
2.66×
TTM Free Cash FlowTrailing 4 quarters
$174.9M
$173.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
STRA
STRA
Q1 26
$87.4M
Q4 25
$86.5M
$39.2M
Q3 25
$58.3M
$60.1M
Q2 25
$44.9M
$31.2M
Q1 25
$49.0M
$67.7M
Q4 24
$51.1M
$15.9M
Q3 24
$56.5M
$51.5M
Q2 24
$22.6M
$24.3M
Free Cash Flow
PEN
PEN
STRA
STRA
Q1 26
$77.3M
Q4 25
$68.0M
$27.0M
Q3 25
$42.0M
$49.3M
Q2 25
$29.4M
$20.4M
Q1 25
$35.5M
$57.3M
Q4 24
$45.7M
$4.7M
Q3 24
$51.0M
$42.1M
Q2 24
$18.1M
$13.6M
FCF Margin
PEN
PEN
STRA
STRA
Q1 26
25.3%
Q4 25
17.7%
8.3%
Q3 25
11.8%
15.4%
Q2 25
8.7%
6.3%
Q1 25
11.0%
18.9%
Q4 24
14.5%
1.5%
Q3 24
16.9%
13.8%
Q2 24
6.0%
4.3%
Capex Intensity
PEN
PEN
STRA
STRA
Q1 26
Q4 25
4.8%
3.8%
Q3 25
4.6%
3.4%
Q2 25
4.6%
3.4%
Q1 25
4.2%
3.4%
Q4 24
1.7%
3.6%
Q3 24
1.8%
3.1%
Q2 24
1.5%
3.4%
Cash Conversion
PEN
PEN
STRA
STRA
Q1 26
2.66×
Q4 25
1.83×
1.03×
Q3 25
1.27×
2.26×
Q2 25
0.99×
0.97×
Q1 25
1.25×
2.27×
Q4 24
1.52×
0.63×
Q3 24
1.91×
1.86×
Q2 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

STRA
STRA

U.S. Higher Education$212.6M69%
Australia/New Zealand$51.8M17%
Education Technology Services$41.5M14%

Related Comparisons